Relaxin-2 does not ameliorate nephropathy in an experimental model of type-1 diabetes.

Dschietzig, Thomas Bernd; Krause-Relle, Katharina; Hennequin, Maud; von Websky, Karoline; Rahnenführer, Jan; Ruppert, Jana; Grön, Hans Jürgen; Armbruster, Franz Paul; Bathgate, Ross A D; Aschenbach, Joerg R; Forssmann, Wolf-Georg; Hocher, Berthold

Dschietzig, Thomas Bernd; Krause-Relle, Katharina; Hennequin, Maud; von Websky, Karoline; Rahnenführer, Jan; Ruppert, Jana; Grön, Hans Jürgen; Armbruster, Franz Paul; Bathgate, Ross A D; Aschenbach, Joerg R; Forssmann, Wolf-Georg; Hocher, Berthold.

Kidney Blood Press Res ; 40(1): 77-88, 2015.

Article in En | MEDLINE | ID: mdl-25791819

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Diabetic Nephropathies/drug therapy; Disease Models, Animal; Relaxin/therapeutic use; Animals; Diabetes Mellitus, Type 1/pathology; Diabetic Nephropathies/pathology; Male; Mice; Mice, Inbred C57BL; Mice, Knockout

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Relaxin / Diabetes Mellitus, Type 1 / Diabetic Nephropathies / Disease Models, Animal Limits: Animals Language: En Journal: Kidney Blood Press Res Journal subject: NEFROLOGIA Year: 2015 Type: Article

Search on Google

XML

PubMed Links